[1]
“Artificial Intelligence in Regulatory Affairs: Transforming Drug Development, Regulatory Decision-Making, and Global Compliance”, JDDHS, vol. 3, no. 03, pp. 20–26, Aug. 2026, doi: 10.21590/twbjdc24.